Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diamyd and Vitamin D3 for Type 1 Diabetes Prevention
NCT02387164Phase 2Terminated
- Sponsor
- Lund University
- Start
- Mar 2015
- Primary completion
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Diamyd in type 1 diabetes mellitus (T1D), sponsored by Lund University. Started Mar 2015; status: terminated.
02
Drugs
Diamyd
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02387164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387164.